New Jersey 2022-2023 Regular Session

New Jersey Assembly Bill A1878 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	ASSEMBLY, No. 1878 STATE OF NEW JERSEY 220th LEGISLATURE PRE-FILED FOR INTRODUCTION IN THE 2022 SESSION
2	2
3	3	ASSEMBLY, No. 1878
4	4
5	5
6	6
7	7	STATE OF NEW JERSEY
8	8
9	9	220th LEGISLATURE
10	10
11	11
12	12
13	13	PRE-FILED FOR INTRODUCTION IN THE 2022 SESSION
14	14
15	15
16	16
17	17	Sponsored by: Assemblyman THOMAS P. GIBLIN District 34 (Essex and Passaic) Assemblyman DANIEL R. BENSON District 14 (Mercer and Middlesex) Co-Sponsored by: Assemblyman Freiman, Assemblywoman Murphy, Assemblyman Stanley, Assemblywomen Lopez, McKnight and Assemblyman Mejia SYNOPSIS Requires pharmacies to provide certain information regarding insulin manufacturer assistance programs. CURRENT VERSION OF TEXT Introduced Pending Technical Review by Legislative Counsel.
18	18
19	19
20	20
21	21	Sponsored by:
22	22
23	23	Assemblyman THOMAS P. GIBLIN
24	24
25	25	District 34 (Essex and Passaic)
26	26
27	27	Assemblyman DANIEL R. BENSON
28	28
29	29	District 14 (Mercer and Middlesex)
30	30
31	31
32	32
33	33	Co-Sponsored by:
34	34
35	35	Assemblyman Freiman, Assemblywoman Murphy, Assemblyman Stanley, Assemblywomen Lopez, McKnight and Assemblyman Mejia
36	36
37	37
38	38
39	39
40	40
41	41
42	42
43	43
44	44
45	45	SYNOPSIS
46	46
47	47	Requires pharmacies to provide certain information regarding insulin manufacturer assistance programs.
48	48
49	49
50	50
51	51	CURRENT VERSION OF TEXT
52	52
53	53	Introduced Pending Technical Review by Legislative Counsel.
54	54
55	55
56	56
57	57	An Act concerning insulin manufacturer assistance programs and supplementing P.L.2003, c.280 (C.45:14-40 et seq.). Be It Enacted by the Senate and General Assembly of the State of New Jersey: 1. a. A pharmacy practice site shall: (1) display a notice concerning insulin manufacturer assistance programs, to be created by the Department of Banking and Insurance, at all points of sale; and (2) provide a pamphlet concerning insulin manufacturer assistance programs, to be created by the department, to an individual purchasing a prescription for insulin and any individual requesting a pamphlet. b. An insulin manufacturer offering an assistance program may inform the department of its intention to be included in the notices and pamphlets. c. The department shall adopt rules and regulations pursuant to the "Administrative Procedure Act," P.L.1968, c.410 (C.52:14B-1 et seq.), to effectuate the purposes of this act. 2. This act shall take effect on the first day of the sixth month next following the date of enactment, except that the Commissioner of Banking and Insurance may take any anticipatory administrative action in advance as shall be necessary for the implementation of this act. STATEMENT This bill requires pharmacies to provide certain information regarding insulin manufacturer assistance programs. Under this bill, a pharmacy practice site will be required to display a notice, created by the Department of Banking and Insurance, concerning insulin manufacturer assistance programs at all points of sale. A pharmacy practice site will also be required to provide a pamphlet, created by the department, concerning the insulin manufacturer assistance programs to any individual purchasing a prescription for insulin, or to any individual requesting a pamphlet. Insulin manufacturers offering an assistance program may inform the department of their intention to be included in the notices and pamphlets.
58	58
59	59	An Act concerning insulin manufacturer assistance programs and supplementing P.L.2003, c.280 (C.45:14-40 et seq.).
60	60
61	61
62	62
63	63	Be It Enacted by the Senate and General Assembly of the State of New Jersey:
64	64
65	65
66	66
67	67	1. a. A pharmacy practice site shall:
68	68
69	69	(1) display a notice concerning insulin manufacturer assistance programs, to be created by the Department of Banking and Insurance, at all points of sale; and
70	70
71	71	(2) provide a pamphlet concerning insulin manufacturer assistance programs, to be created by the department, to an individual purchasing a prescription for insulin and any individual requesting a pamphlet.
72	72
73	73	b. An insulin manufacturer offering an assistance program may inform the department of its intention to be included in the notices and pamphlets.
74	74
75	75	c. The department shall adopt rules and regulations pursuant to the "Administrative Procedure Act," P.L.1968, c.410 (C.52:14B-1 et seq.), to effectuate the purposes of this act.
76	76
77	77
78	78
79	79	2. This act shall take effect on the first day of the sixth month next following the date of enactment, except that the Commissioner of Banking and Insurance may take any anticipatory administrative action in advance as shall be necessary for the implementation of this act.
80	80
81	81
82	82
83	83
84	84
85	85	STATEMENT
86	86
87	87
88	88
89	89	This bill requires pharmacies to provide certain information regarding insulin manufacturer assistance programs.
90	90
91	91	Under this bill, a pharmacy practice site will be required to display a notice, created by the Department of Banking and Insurance, concerning insulin manufacturer assistance programs at all points of sale. A pharmacy practice site will also be required to provide a pamphlet, created by the department, concerning the insulin manufacturer assistance programs to any individual purchasing a prescription for insulin, or to any individual requesting a pamphlet. Insulin manufacturers offering an assistance program may inform the department of their intention to be included in the notices and pamphlets.